Berkers Celia R, de Jong Annemieke, Schuurman Karianne G, Linnemann Carsten, Meiring Hugo D, Janssen Lennert, Neefjes Jacques J, Schumacher Ton N M, Rodenko Boris, Ovaa Huib
Division of Cell Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;
Division of Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; and.
J Immunol. 2015 Nov 1;195(9):4085-95. doi: 10.4049/jimmunol.1402455. Epub 2015 Sep 23.
Peptide splicing, in which two distant parts of a protein are excised and then ligated to form a novel peptide, can generate unique MHC class I-restricted responses. Because these peptides are not genetically encoded and the rules behind proteasomal splicing are unknown, it is difficult to predict these spliced Ags. In the current study, small libraries of short peptides were used to identify amino acid sequences that affect the efficiency of this transpeptidation process. We observed that splicing does not occur at random, neither in terms of the amino acid sequences nor through random splicing of peptides from different sources. In contrast, splicing followed distinct rules that we deduced and validated both in vitro and in cells. Peptide ligation was quantified using a model peptide and demonstrated to occur with up to 30% ligation efficiency in vitro, provided that optimal structural requirements for ligation were met by both ligating partners. In addition, many splicing products could be formed from a single protein. Our splicing rules will facilitate prediction and detection of new spliced Ags to expand the peptidome presented by MHC class I Ags.
肽剪接是指将蛋白质的两个远距离部分切除,然后连接形成一种新的肽,它可以产生独特的MHC I类限制性反应。由于这些肽不是基因编码的,且蛋白酶体剪接背后的规则尚不清楚,因此很难预测这些剪接抗原。在本研究中,使用短肽小文库来鉴定影响这种转肽过程效率的氨基酸序列。我们观察到,剪接并非随机发生,无论是在氨基酸序列方面,还是通过不同来源肽的随机剪接。相反,剪接遵循我们在体外和细胞中推导并验证的明确规则。使用模型肽对肽连接进行了定量,结果表明,只要连接伙伴双方满足连接的最佳结构要求,体外连接效率可达30%。此外,单个蛋白质可以形成许多剪接产物。我们的剪接规则将有助于预测和检测新的剪接抗原,以扩展MHC I类抗原呈递的肽组。